PropertyValue
?:abstract
  • Most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in pediatric patients are mild or asymptomatic. However, infants have emerged at higher risk of hospitalization and severe outcomes in pediatric coronavirus disease 2019 (COVID-19). We report a case series of 4 full-term neonates hospitalized with fever and found to have SARS-CoV-2 infection with a spectrum of illness severities. Two neonates required admission to the intensive care unit for respiratory insufficiency and end organ involvement. Half of the patients were found to have a coinfection. One neonate received antiviral therapy with remdesivir and is, to our knowledge, the youngest patient to receive this drug for COVID-19. All neonates had favorable outcomes.
?:creator
?:doi
?:doi
  • 10.1093/jpids/piaa084
?:journal
  • J_Pediatric_Infect_Dis_Soc
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/1633f2dec34b95bdb6c165c32c8d7c180f08c6fe.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7454701.xml.json
?:pmcid
?:pmid
?:pmid
  • 32645175.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Febrile Neonates
?:type
?:year
  • 2020-07-09

Metadata

Anon_0  
expand all